Skip to main content
Top
Published in: Lung 6/2016

Open Access 01-12-2016

The Effect of Fatigue and Fatigue Intensity on Exercise Tolerance in Moderate COPD

Authors: Khaled Al-shair, Umme Kolsum, Dave Singh, Jørgen Vestbo

Published in: Lung | Issue 6/2016

Login to get access

Abstract

Introduction

Fatigue is one of the most disabling symptoms in COPD, but little is known about the impact of fatigue on functional disability. We explored the impact of fatigue and fatigue intensity on exercise tolerance after adjusting for other factors using multivariate analysis and compared it to that of dyspnoea.

Methods

A total of 119 patients with mainly moderate–severe stable COPD (38 % women, mean age 66 years) were enrolled. We used the Medical Research Council dyspnoea scores (MRC), Manchester COPD fatigue scale (MCFS) and its three dimensions, Borg scales for fatigue and dyspnoea, six-minute walk distance (6MWD), St George’s Respiratory Questionnaire, the BODE index, and the Centre for Epidemiological Study on Depression scale (CES-D), and we measured spirometry, blood gases, systemic inflammatory markers and fat-free mass index (FFMI).

Results

Fatigue measured using the MCFS was associated with 6MWD and explained 22 % of the variability in 6MWD (p < 0.001). Fatigue remained associated with 6MWD after adjusting for MRC dyspnoea, FFMI and FEV1, FVC, PaO2, PaCO2, CES-D, TNF-alpha, smoking status, age and gender. We found that 33, 50 and 23 % of patients reported an increase by 2 scores on Borg scales for fatigue, dyspnoea or both at the end of the 6MWT. Fatigue scores (both before and after the 6MWT) were negatively correlated with 6MWD after adjusting for FEV1, FFMI, CES-D score and age (p = 0.007 and 0.001, respectively).

Conclusion

In moderate stable COPD, fatigue may be a central driver of functional disability, to the same extent as dyspnoea.
Appendix
Available only for authorised users
Literature
1.
go back to reference Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A et al (2013) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 187(4):347–365CrossRefPubMed Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A et al (2013) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 187(4):347–365CrossRefPubMed
2.
go back to reference Pitta F, Troosters T, Probst VS, Langer D, Decramer M, Gosselink R (2008) Are patients with COPD more active after pulmonary rehabilitation? Chest 134(2):273–280CrossRefPubMed Pitta F, Troosters T, Probst VS, Langer D, Decramer M, Gosselink R (2008) Are patients with COPD more active after pulmonary rehabilitation? Chest 134(2):273–280CrossRefPubMed
3.
go back to reference Jones PW, Quirk FH, Baveystock CM, Littlejohns P (1992) A self-complete measure of health status for chronic airflow limitation: the St. George’s Respiratory Questionnaire. Am Rev Respir Dis 145(6):1321–1327CrossRefPubMed Jones PW, Quirk FH, Baveystock CM, Littlejohns P (1992) A self-complete measure of health status for chronic airflow limitation: the St. George’s Respiratory Questionnaire. Am Rev Respir Dis 145(6):1321–1327CrossRefPubMed
4.
go back to reference Al-shair K, Dockry R, Mallia-Milanes B, Kolsum U, Singh D, Vestbo J (2009) Depression and its relationship with poor exercise capacity, BODE index and muscle wasting in COPD. Respir Med 103(10):1572–1579CrossRefPubMed Al-shair K, Dockry R, Mallia-Milanes B, Kolsum U, Singh D, Vestbo J (2009) Depression and its relationship with poor exercise capacity, BODE index and muscle wasting in COPD. Respir Med 103(10):1572–1579CrossRefPubMed
5.
go back to reference Spruit MA, Watkins ML, Edwards LD, Vestbo J, Calverley PM, Pinto-Plata V et al (2010) Determinants of poor 6-min walking distance in patients with COPD: the ECLIPSE cohort. Respir Med 104(6):849–857CrossRefPubMed Spruit MA, Watkins ML, Edwards LD, Vestbo J, Calverley PM, Pinto-Plata V et al (2010) Determinants of poor 6-min walking distance in patients with COPD: the ECLIPSE cohort. Respir Med 104(6):849–857CrossRefPubMed
6.
go back to reference Hanania NA, Mullerova H, Locantore NW, Vestbo J, Watkins ML, Wouters EF et al (2011) Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort. Am J Respir Crit Care Med 183(5):604–611CrossRefPubMed Hanania NA, Mullerova H, Locantore NW, Vestbo J, Watkins ML, Wouters EF et al (2011) Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort. Am J Respir Crit Care Med 183(5):604–611CrossRefPubMed
7.
go back to reference Cote CG, Pinto-Plata V, Kasprzyk K, Dordelly LJ, Celli BR (2007) The 6-min walk distance, peak oxygen uptake, and mortality in COPD. Chest 132(6):1778–1785CrossRefPubMed Cote CG, Pinto-Plata V, Kasprzyk K, Dordelly LJ, Celli BR (2007) The 6-min walk distance, peak oxygen uptake, and mortality in COPD. Chest 132(6):1778–1785CrossRefPubMed
8.
go back to reference Casanova C, Cote C, Marin JM, Pinto-Plata V, de Torres JP, Aguirre-Jaime A et al (2008) Distance and oxygen desaturation during the 6-min walk test as predictors of long-term mortality in patients with COPD. Chest 134(4):746–752CrossRefPubMed Casanova C, Cote C, Marin JM, Pinto-Plata V, de Torres JP, Aguirre-Jaime A et al (2008) Distance and oxygen desaturation during the 6-min walk test as predictors of long-term mortality in patients with COPD. Chest 134(4):746–752CrossRefPubMed
9.
go back to reference Martinez FJ, Foster G, Curtis JL, Criner G, Weinmann G, Fishman A et al (2006) Predictors of mortality in patients with emphysema and severe airflow obstruction. Am J Respir Crit Care Med 173(12):1326–1334CrossRefPubMedPubMedCentral Martinez FJ, Foster G, Curtis JL, Criner G, Weinmann G, Fishman A et al (2006) Predictors of mortality in patients with emphysema and severe airflow obstruction. Am J Respir Crit Care Med 173(12):1326–1334CrossRefPubMedPubMedCentral
10.
go back to reference Kapella MC, Larson JL, Patel MK, Covey MK, Berry JK (2006) Subjective fatigue, influencing variables, and consequences in chronic obstructive pulmonary disease. Nurs Res 55(1):10–17CrossRefPubMed Kapella MC, Larson JL, Patel MK, Covey MK, Berry JK (2006) Subjective fatigue, influencing variables, and consequences in chronic obstructive pulmonary disease. Nurs Res 55(1):10–17CrossRefPubMed
11.
go back to reference American Thoracic Society (2002) ATS Statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166:111–117CrossRef American Thoracic Society (2002) ATS Statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166:111–117CrossRef
12.
go back to reference Ischaki E, Papatheodorou G, Gaki E, Papa I, Koulouris N, Loukides S (2007) Body mass and fat-free mass indices in COPD: relation with variables expressing disease severity. Chest 132(1):164–169CrossRefPubMed Ischaki E, Papatheodorou G, Gaki E, Papa I, Koulouris N, Loukides S (2007) Body mass and fat-free mass indices in COPD: relation with variables expressing disease severity. Chest 132(1):164–169CrossRefPubMed
13.
go back to reference Broekhuizen R, Wouters EF, Creutzberg EC, Schols AM (2006) Raised CRP levels mark metabolic and functional impairment in advanced COPD. Thorax 61(1):17–22CrossRefPubMed Broekhuizen R, Wouters EF, Creutzberg EC, Schols AM (2006) Raised CRP levels mark metabolic and functional impairment in advanced COPD. Thorax 61(1):17–22CrossRefPubMed
14.
go back to reference de Torres JP, Pinto-Plata V, Casanova C, Mullerova H, Cordoba-Lanus E, Muros de Fuentes M et al (2008) C-reactive protein levels and survival in patients with moderate to very severe COPD. Chest 133(6):1336–1343CrossRefPubMed de Torres JP, Pinto-Plata V, Casanova C, Mullerova H, Cordoba-Lanus E, Muros de Fuentes M et al (2008) C-reactive protein levels and survival in patients with moderate to very severe COPD. Chest 133(6):1336–1343CrossRefPubMed
15.
go back to reference Man WD, Soliman MG, Gearing J, Radford SG, Rafferty GF, Gray BJ et al (2003) Symptoms and quadriceps fatigability after walking and cycling in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 168(5):562–567CrossRefPubMed Man WD, Soliman MG, Gearing J, Radford SG, Rafferty GF, Gray BJ et al (2003) Symptoms and quadriceps fatigability after walking and cycling in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 168(5):562–567CrossRefPubMed
16.
go back to reference Onorati P, Antonucci R, Valli G, Berton E, De Marco F, Serra P et al (2003) Non-invasive evaluation of gas exchange during a shuttle walking test vs. a 6-min walking test to assess exercise tolerance in COPD patients. Eur J Appl Physiol 89(3–4):331–336CrossRefPubMed Onorati P, Antonucci R, Valli G, Berton E, De Marco F, Serra P et al (2003) Non-invasive evaluation of gas exchange during a shuttle walking test vs. a 6-min walking test to assess exercise tolerance in COPD patients. Eur J Appl Physiol 89(3–4):331–336CrossRefPubMed
17.
go back to reference Killian KJ, Leblanc P, Martin DH, Summers E, Jones NL, Campbell EJ (1992) Exercise capacity and ventilatory, circulatory, and symptom limitation in patients with chronic airflow limitation. Am Rev Respir Dis 146(4):935–940CrossRefPubMed Killian KJ, Leblanc P, Martin DH, Summers E, Jones NL, Campbell EJ (1992) Exercise capacity and ventilatory, circulatory, and symptom limitation in patients with chronic airflow limitation. Am Rev Respir Dis 146(4):935–940CrossRefPubMed
18.
go back to reference Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Anto JM (2006) Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax 61(9):772–778CrossRefPubMedPubMedCentral Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Anto JM (2006) Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax 61(9):772–778CrossRefPubMedPubMedCentral
19.
go back to reference Breslin E, van der Schans C, Breukink S, Meek P, Mercer K, Volz W et al (1998) Perception of fatigue and quality of life in patients with COPD. Chest 114:958–964CrossRefPubMed Breslin E, van der Schans C, Breukink S, Meek P, Mercer K, Volz W et al (1998) Perception of fatigue and quality of life in patients with COPD. Chest 114:958–964CrossRefPubMed
20.
go back to reference Paddison JS, Effing TW, Quinn S, Frith PA (2013) Fatigue in COPD: association with functional status and hospitalisations. Eur Respir J 41(3):565–570CrossRefPubMed Paddison JS, Effing TW, Quinn S, Frith PA (2013) Fatigue in COPD: association with functional status and hospitalisations. Eur Respir J 41(3):565–570CrossRefPubMed
21.
go back to reference Al-Shair K, Muellerova H, Yorke J, Rennard SI, Wouters EF, Hanania NA et al (2012) Examining fatigue in COPD: development, validity and reliability of a modified version of FACIT-F scale. Health Qual Life Outcomes 10(1):100CrossRefPubMedPubMedCentral Al-Shair K, Muellerova H, Yorke J, Rennard SI, Wouters EF, Hanania NA et al (2012) Examining fatigue in COPD: development, validity and reliability of a modified version of FACIT-F scale. Health Qual Life Outcomes 10(1):100CrossRefPubMedPubMedCentral
22.
go back to reference Al-shair K, Muldoon EG, Morris J, Atherton GT, Kosmidis C, Denning DW (2016) Characterisation of fatigue and its substantial impact on health status in a large cohort of patients with chronic pulmonary aspergillosis (CPA). Respir Med 114:117–122CrossRefPubMed Al-shair K, Muldoon EG, Morris J, Atherton GT, Kosmidis C, Denning DW (2016) Characterisation of fatigue and its substantial impact on health status in a large cohort of patients with chronic pulmonary aspergillosis (CPA). Respir Med 114:117–122CrossRefPubMed
23.
go back to reference Evans RA, Singh SJ, Collier R, Williams JE, Morgan MD (2009) Pulmonary rehabilitation is successful for COPD irrespective of MRC dyspnoea grade. Respir Med 103(7):1070–1075CrossRefPubMed Evans RA, Singh SJ, Collier R, Williams JE, Morgan MD (2009) Pulmonary rehabilitation is successful for COPD irrespective of MRC dyspnoea grade. Respir Med 103(7):1070–1075CrossRefPubMed
24.
go back to reference Williams JE, Singh SJ, Sewell L, Morgan MD (2003) Health status measurement: sensitivity of the self-reported Chronic Respiratory Questionnaire (CRQ-SR) in pulmonary rehabilitation. Thorax 58(6):515–518CrossRefPubMedPubMedCentral Williams JE, Singh SJ, Sewell L, Morgan MD (2003) Health status measurement: sensitivity of the self-reported Chronic Respiratory Questionnaire (CRQ-SR) in pulmonary rehabilitation. Thorax 58(6):515–518CrossRefPubMedPubMedCentral
25.
go back to reference Baltzan MA, Scott AS, Wolkove N, Bailes S, Bernard S, Bourbeau J et al (2011) Fatigue in COPD: prevalence and effect on outcomes in pulmonary rehabilitation. Chron Respir Dis 8(2):119–128PubMed Baltzan MA, Scott AS, Wolkove N, Bailes S, Bernard S, Bourbeau J et al (2011) Fatigue in COPD: prevalence and effect on outcomes in pulmonary rehabilitation. Chron Respir Dis 8(2):119–128PubMed
26.
go back to reference Arslan S, Oztunc G (2015) The effects of a walking exercise program on fatigue in the person with COPD. Rehabil Nurs Off J Assoc Rehabil Nurs. doi:10.1002/rnj.206 Arslan S, Oztunc G (2015) The effects of a walking exercise program on fatigue in the person with COPD. Rehabil Nurs Off J Assoc Rehabil Nurs. doi:10.​1002/​rnj.​206
27.
go back to reference Al-Shair K, Kolsum U, Berry P, Smith J, Caress A, Singh D et al (2009) Development, dimensions, reliability and validity of the novel Manchester COPD fatigue scale. Thorax 64(11):950–955CrossRefPubMed Al-Shair K, Kolsum U, Berry P, Smith J, Caress A, Singh D et al (2009) Development, dimensions, reliability and validity of the novel Manchester COPD fatigue scale. Thorax 64(11):950–955CrossRefPubMed
28.
go back to reference Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA (1999) Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 54:581–586CrossRefPubMedPubMedCentral Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA (1999) Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 54:581–586CrossRefPubMedPubMedCentral
29.
go back to reference Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA et al (2004) The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 350(10):1005–1012CrossRefPubMed Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA et al (2004) The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 350(10):1005–1012CrossRefPubMed
30.
go back to reference Cote CG, Casanova C, Marin JM, Lopez MV, Pinto-Plata V, de Oca MM et al (2008) Validation and comparison of reference equations for the 6-min walk distance test. Eur Respir J 31(3):571–578CrossRefPubMed Cote CG, Casanova C, Marin JM, Lopez MV, Pinto-Plata V, de Oca MM et al (2008) Validation and comparison of reference equations for the 6-min walk distance test. Eur Respir J 31(3):571–578CrossRefPubMed
31.
go back to reference Radloff LS (1977) The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1:385–401CrossRef Radloff LS (1977) The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1:385–401CrossRef
32.
go back to reference Schols AM, Soeters PB, Dingemans AM, Mostert R, Frantzen PJ, Wouters EF (1993) Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am Rev Respir Dis 147:1151–1156CrossRefPubMed Schols AM, Soeters PB, Dingemans AM, Mostert R, Frantzen PJ, Wouters EF (1993) Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am Rev Respir Dis 147:1151–1156CrossRefPubMed
33.
34.
go back to reference Ries AL (2005) Minimally clinically important difference for the UCSD Shortness of Breath Questionnaire, Borg Scale, and Visual Analog Scale. COPD 2(1):105–110CrossRefPubMed Ries AL (2005) Minimally clinically important difference for the UCSD Shortness of Breath Questionnaire, Borg Scale, and Visual Analog Scale. COPD 2(1):105–110CrossRefPubMed
35.
go back to reference Cazzola M, MacNee W, Martinez FJ, Rabe KF, Franciosi LG, Barnes PJ et al (2008) Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J 31(2):416–469CrossRefPubMed Cazzola M, MacNee W, Martinez FJ, Rabe KF, Franciosi LG, Barnes PJ et al (2008) Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J 31(2):416–469CrossRefPubMed
36.
go back to reference Miller MR, Crapo R, Hankinson J, Brusasco V et al (2005) Standardisation of spirometry “ATS/ERS task force: standardisation of lung function testing”. Eur Resp J 26:319–338CrossRef Miller MR, Crapo R, Hankinson J, Brusasco V et al (2005) Standardisation of spirometry “ATS/ERS task force: standardisation of lung function testing”. Eur Resp J 26:319–338CrossRef
37.
go back to reference Spiro SG, Dowdeswell IRG (1976) Arterialized ear lobe blood samples for blood gas tensions. Br J Dis Chest 70:263–268CrossRefPubMed Spiro SG, Dowdeswell IRG (1976) Arterialized ear lobe blood samples for blood gas tensions. Br J Dis Chest 70:263–268CrossRefPubMed
38.
go back to reference Steiner MC, Singh SJ, Morgan MD (2005) The contribution of peripheral muscle function to shuttle walking performance in patients with chronic obstructive pulmonary disease. J Cardiopulm Rehabil 25(1):43–49CrossRefPubMed Steiner MC, Singh SJ, Morgan MD (2005) The contribution of peripheral muscle function to shuttle walking performance in patients with chronic obstructive pulmonary disease. J Cardiopulm Rehabil 25(1):43–49CrossRefPubMed
39.
go back to reference Watz H, Waschki B, Boehme C, Claussen M, Meyer T, Magnussen H (2008) Extrapulmonary effects of chronic obstructive pulmonary disease on physical activity: a cross-sectional study. Am J Respir Crit Care Med 177(7):743–751CrossRefPubMed Watz H, Waschki B, Boehme C, Claussen M, Meyer T, Magnussen H (2008) Extrapulmonary effects of chronic obstructive pulmonary disease on physical activity: a cross-sectional study. Am J Respir Crit Care Med 177(7):743–751CrossRefPubMed
40.
go back to reference Scharf SM, Maimon N, Simon-Tuval T, Bernhard-Scharf BJ, Reuveni H, Tarasiuk A (2011) Sleep quality predicts quality of life in chronic obstructive pulmonary disease. Int J Chron Obstr Pulm Dis 6:1–12 Scharf SM, Maimon N, Simon-Tuval T, Bernhard-Scharf BJ, Reuveni H, Tarasiuk A (2011) Sleep quality predicts quality of life in chronic obstructive pulmonary disease. Int J Chron Obstr Pulm Dis 6:1–12
41.
go back to reference Calvert LD, Steiner MC, Morgan MD, Singh SJ (2010) Plasma ammonia response to incremental cycling and walking tests in COPD. Respir Med 104(5):675–681CrossRefPubMed Calvert LD, Steiner MC, Morgan MD, Singh SJ (2010) Plasma ammonia response to incremental cycling and walking tests in COPD. Respir Med 104(5):675–681CrossRefPubMed
42.
go back to reference Janson-Bjerklie S, Carrieri VK, Hudes M (1986) Thesensations of pulmonary dyspnea. Nurs Res 35:154–159CrossRefPubMed Janson-Bjerklie S, Carrieri VK, Hudes M (1986) Thesensations of pulmonary dyspnea. Nurs Res 35:154–159CrossRefPubMed
43.
go back to reference Baghai-Ravary R, Quint JK, Goldring JJ, Hurst JR, Donaldson GC, Wedzicha JA (2009) Determinants and impact of fatigue in patients with chronic obstructive pulmonary disease. Respir Med 103(2):216–223CrossRefPubMed Baghai-Ravary R, Quint JK, Goldring JJ, Hurst JR, Donaldson GC, Wedzicha JA (2009) Determinants and impact of fatigue in patients with chronic obstructive pulmonary disease. Respir Med 103(2):216–223CrossRefPubMed
44.
go back to reference Al-Shair K, Müllerova H, Locantore N, Hanania NA, Sharafkhaneh A, Wouters E et al (2011) Fatigue in COPD is significantly associated with exacerbations; data from the ECLIPSE cohort study. Am J Respir Crit Care Med 183:A3974 Al-Shair K, Müllerova H, Locantore N, Hanania NA, Sharafkhaneh A, Wouters E et al (2011) Fatigue in COPD is significantly associated with exacerbations; data from the ECLIPSE cohort study. Am J Respir Crit Care Med 183:A3974
45.
go back to reference Gift AG, Pugh LC (1993) Dyspnea and fatigue. Nurs Clin North Am 28(2):373–384PubMed Gift AG, Pugh LC (1993) Dyspnea and fatigue. Nurs Clin North Am 28(2):373–384PubMed
46.
go back to reference Al-shair K, Kolsum U, Dockry R, Morris J, Singh D, Vestbo J (2011) Biomarkers of systemic inflammation and depression and fatigue in moderate clinically stable COPD. Respir Res 12:3CrossRefPubMedPubMedCentral Al-shair K, Kolsum U, Dockry R, Morris J, Singh D, Vestbo J (2011) Biomarkers of systemic inflammation and depression and fatigue in moderate clinically stable COPD. Respir Res 12:3CrossRefPubMedPubMedCentral
47.
go back to reference Spruit MA, Pennings HJ, Janssen PP, Does JD, Scroyen S, Akkermans MA et al (2007) Extra-pulmonary features in COPD patients entering rehabilitation after stratification for MRC dyspnea grade. Respir Med 101(12):2454–2463CrossRefPubMed Spruit MA, Pennings HJ, Janssen PP, Does JD, Scroyen S, Akkermans MA et al (2007) Extra-pulmonary features in COPD patients entering rehabilitation after stratification for MRC dyspnea grade. Respir Med 101(12):2454–2463CrossRefPubMed
48.
go back to reference Garrod R, Marshall J, Barley E, Jones PW (2006) Predictors of success and failure in pulmonary rehabilitation. Eur Respir J 27(4):788–794CrossRefPubMed Garrod R, Marshall J, Barley E, Jones PW (2006) Predictors of success and failure in pulmonary rehabilitation. Eur Respir J 27(4):788–794CrossRefPubMed
Metadata
Title
The Effect of Fatigue and Fatigue Intensity on Exercise Tolerance in Moderate COPD
Authors
Khaled Al-shair
Umme Kolsum
Dave Singh
Jørgen Vestbo
Publication date
01-12-2016
Publisher
Springer US
Published in
Lung / Issue 6/2016
Print ISSN: 0341-2040
Electronic ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-016-9931-y

Other articles of this Issue 6/2016

Lung 6/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.